Vasta Lauren M, McMaster Mary L, Harney Laura A, Ling Alexander, Kim Jung, Harris Anne K, Carr Ann G, Damrauer Scott M, Rader Daniel J, Kember Rachel L, Kanetsky Peter A, Nathanson Katherine L, Pyle Louise C, Greene Mark H, Schultz Kris Ann, Stewart Douglas R
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA; National Capital Consortium, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, MD, USA; Commissioned Corps of the United States Public Health Service.
Cancer Genet. 2020 Oct;248-249:49-56. doi: 10.1016/j.cancergen.2020.10.002. Epub 2020 Oct 24.
Several studies have reported conflicting evidence on the inclusion of testicular germ cell tumors (TGCT) in the DICER1 tumor-predisposition phenotype. We evaluated the relationship between DICER1 and TGCT by reviewing scrotal ultrasounds of males with pathogenic germline variants in DICER1 and queried exome data from TGCT-affected men for DICER1 variants.
Fifty-four male DICER1-carriers and family controls (n=41) enrolled in the National Cancer Institute (NCI) DICER1 Natural History Study were offered scrotal ultrasounds. These studies were examined by a single radiologist for abnormalities. In parallel, DICER1 variants from two large exome-sequenced TGCT cohorts were extracted. We used previously published AMG-AMP criteria to characterize rare DICER1 variants.
There was no observed difference in frequency of testicular cystic structures in DICER1-carriers versus controls. DICER1 variation was not associated with TGCT in the NCI DICER1-carriers. In 1,264 exome-sequenced men with TGCT, none harbored ClinVar- or InterVar-determined pathogenic or likely pathogenic variants in DICER1. Three DICER1 variants of uncertain significance (one case and two controls) were predicted "damaging" based on a priori criteria.
Using two complementary approaches, we found no evidence of an association between pathogenic DICER1 variants and TGCT.
多项研究报告了关于睾丸生殖细胞肿瘤(TGCT)是否纳入DICER1肿瘤易感性表型的相互矛盾的证据。我们通过回顾携带DICER1致病种系变异男性的阴囊超声检查,并查询受TGCT影响男性的外显子组数据以寻找DICER1变异,评估了DICER1与TGCT之间的关系。
参加美国国立癌症研究所(NCI)DICER1自然史研究的54名携带DICER1的男性及其家族对照(n = 41)接受了阴囊超声检查。这些检查由一名放射科医生进行异常检查。同时,从两个大型外显子组测序的TGCT队列中提取DICER1变异。我们使用先前发表的AMG-AMP标准来表征罕见的DICER1变异。
在携带DICER1的个体与对照中,未观察到睾丸囊性结构频率的差异。在NCI携带DICER1的个体中,DICER1变异与TGCT无关。在1264名经外显子组测序的TGCT男性中,没有人携带ClinVar或InterVar确定的DICER1致病或可能致病变异。根据先验标准,三个意义未明的DICER1变异(1例病例和2例对照)被预测为“有害”。
通过两种互补方法,我们未发现致病DICER1变异与TGCT之间存在关联的证据。